All In Biotech

NDA 020734 · Baxter Hlthcare

Clinimix 8/14 Sulfite Free In Dextrose 14% In Plastic Container

Amino Acids, Dextrose · Injection · Amino Acid

Last checked: Nov 20, 2026Latest source record: Apr 13, 2021 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1997

Sep 29, 1997

Approved uses

2

Original approval plus efficacy supplements

Registered trials

30,323

6,603 Phase 3, 2,682 recruiting

FAERS reports

66

42 serious, 14 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Apr 13, 2021.

CLINIMIX is indicated as a source of calories and protein for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. CLINIMIX may be used to treat negative nitrogen balance in patients. CLINIMIX is indicated as a source of calories and protein for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. CLINIMIX may be used to treat negative nitrogen balance in patients. ( 1 )

Mechanism: CLINIMIX is used as a supplement of nutrition in patients, providing macronutrients (amino acids and dextrose) parenterally. The amino acids provide the structural units that make up proteins and are used to synthesize proteins and other biomolecules or are oxidized to urea and carbon dioxide as a source of energy. The administered dextrose is oxidized to carbon dioxide and water, yielding energy.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Apr 12, 2000 Supplement 3 · Efficacy Letter
  • Sep 29, 1997 Original approval · Type 4 - New Combination
13 products under this application
  • CLINIMIX 8/14 SULFITE FREE IN DEXTROSE 14% IN PLASTIC CONTAINER · AMINO ACIDS 8%; DEXTROSE 14GM/100ML · INJECTABLE, INJECTION · Prescription
  • CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER · AMINO ACIDS 5%; DEXTROSE 25GM/100ML · INJECTABLE, INJECTION · Prescription
  • CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER · AMINO ACIDS 5%; DEXTROSE 15GM/100ML · INJECTABLE, INJECTION · Prescription
  • CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER · AMINO ACIDS 4.25%; DEXTROSE 5GM/100ML · INJECTABLE, INJECTION · Prescription
  • CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER · AMINO ACIDS 2.75%; DEXTROSE 25GM/100ML · INJECTABLE, INJECTION · Prescription
  • CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER · AMINO ACIDS 4.25%; DEXTROSE 25GM/100ML · INJECTABLE, INJECTION · Prescription
  • CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER · AMINO ACIDS 2.75%; DEXTROSE 5GM/100ML · INJECTABLE, INJECTION · Prescription
  • CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER · AMINO ACIDS 5%; DEXTROSE 35GM/100ML · INJECTABLE, INJECTION · Prescription
  • CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER · AMINO ACIDS 5%; DEXTROSE 20GM/100ML · INJECTABLE, INJECTION · Prescription
  • CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER · AMINO ACIDS 4.25%; DEXTROSE 10GM/100ML · INJECTABLE, INJECTION · Prescription
  • CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER · AMINO ACIDS 5%; DEXTROSE 10GM/100ML · INJECTABLE, INJECTION · Prescription
  • CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER · AMINO ACIDS 4.25%; DEXTROSE 20GM/100ML · INJECTABLE, INJECTION · Prescription
  • CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER · AMINO ACIDS 2.75%; DEXTROSE 10GM/100ML · INJECTABLE, INJECTION · Prescription

Clinical trials

Interventional ClinicalTrials.gov studies with "Amino Acids" as an intervention, any sponsor and status, largest first.

All 30,323 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • pyrexia9
  • erythema6
  • nausea6
  • stevens-johnson syndrome5
  • wrong technique in drug usage process5
  • blister4
  • general physical health deterioration4
  • lip erosion4
  • malaise4
  • medication error4
  • no adverse event4
  • abdominal pain3

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20041
20071
20085
20092
20121
20136
20145
20156
20164
20171
20182
20193
20201
202110
20227
20231
20246
20252
20262

Recalls

1 FDA enforcement reports for this application.

  • Nov 18, 2013 · Class I · Terminated

    Presence of Particulate Matter: Particulate matter includes wood, sodium citrate and dextrose.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 3,551 on PubMed

Sponsor: Baxter Hlthcare · Also marketed as Clinimix 5/25 Sulfite Free In Dextrose 25% In Plastic Container, Clinimix 5/15 Sulfite Free In Dextrose 15% In Plastic Container, Clinimix 4.25/5 Sulfite Free In Dextrose 5% In Plastic Container, Clinimix 2.75/25 Sulfite Free In Dextrose 25% In Plastic Container, Clinimix 4.25/25 Sulfite Free In Dextrose 25% In Plastic Container

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.